| Disease Name |
Alzheimer Disease |
| Nocoding RNA Name |
hsa-miR-132 |
| Expression Pattern |
down-regulated |
| Species |
Homo sapiens |
| Detection Methods |
sequencing,microarray,RT-PCR,Western Blot,Luciferase Reporter Assay,transfection,Immunofluorescence,ELISA etc. |
| Target |
ITPKB |
| Tissue |
Hippocampal and Prefrontal cortex tissue |
| Treatment |
N/A
|
| PubMed ID |
27485122 |
| Year |
2016 |
| Detail Description |
MiR-132 loss exacerbates both amyloid and TAU pathology via inositol 1,4,5-trisphosphate 3-kinase B (ITPKB) upregulation in an AD mouse model.This leads to increased ERK1/2 and BACE1 activity and elevated TAU phosphorylation.We confirm downregulation of miR-132 and upregulation of ITPKB in three distinct human AD patient cohorts. |
|